1-5 of 5
Jerry Bryant
Close
Sort by
Journal Articles

Synergistic Effect of Cannabidiol with Conventional Chemotherapy Treatment

Tori Strong, PhD, Jana Rauvolfova, PhD, Elias Jackson, PhD, Lan V. Pham, PhD, Jerry Bryant
Journal: Blood
Blood (2018) 132 (Supplement 1): 5382.
https://doi.org/10.1182/blood-2018-99-116749
Published: 2018
Journal Articles

Cannabinoid Receptor Signaling As a Target for Personalized Therapy in Aggressive B Cell Lymphomas

Lan Pham, PhD, Juan Chen, PhD, Archie Tamayo, MS, Jerry Bryant, David Yang, PhD, Richard J. Ford, Jr., MD PhD
Journal: Blood
Blood (2016) 128 (22): 4181.
https://doi.org/10.1182/blood.V128.22.4181.4181
Published: 2016
Journal Articles

Reversing Metabolic and Epigenetic Cellular Alterations to Overcome Chemo-Resistance in Aggressive B Cell Lymphomas

Kejie Zhang, MD, PhD, Lan V Pham, PhD, Archito T. Tamayo, MS, John Lee, MD, Jerry Bryant, M.S., Anas Younes, MD, Luis E Fayad, MD, David J Yang, Ph.D, Richard J. Ford, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 1305.
https://doi.org/10.1182/blood.V120.21.1305.1305
Published: 2012
Journal Articles

The Hexosamine Biosyntheic Pathway and Platinum-Ethylenedicysteine-Glucosamine (Pt-ECG) for Targeted Therapy in Diffuse Large B-Cell Lymphoma

Lan V Pham, PhD, Jerry Bryant, M.S., Archito T. Tamayo, MS, Richard Mendez, M.S., Edna Chum, David J Yang, Ph.D, David Rollo, MD, Ph.D, Richard J. Ford, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 587.
https://doi.org/10.1182/blood.V118.21.587.587
Published: 2011
Journal Articles

Metabolic Targeted Therapy for Aggressive B-Cell Lymphomas: Evaluating Glucose Metabolism and the Potential of 187 rhenium- Ethylenedicysteine –N-AcetylGlucosamine ( 187 Re-ECG) for Therapy

Lan V Pham, Ph.D, Jerry Bryant, M.S., Archito Tamayo, M.S., Richard Mendez, M.S., Edna Chum, David Yang, Ph.D, David Rollo, MD, Ph.D, Richard J. Ford, JR, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 117.
https://doi.org/10.1182/blood.V116.21.117.117
Published: 2010